| Pfizer AG - Adriblastin Solution 50 mg/25 ml, Injektionslösung |
| 50358 | | 03 | | Adriblastin Solution 50 mg/25 ml | | Injektionslösung | | L01DB01 | | Doxorubicin | | 24.06.1991 | | |
|
| Composition |
| doxorubicini hydrochloridum 50 mg, natrii chloridum corresp. natrium 88.5 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 25 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Doxorubicin Hydrochloride | 50mg / 25ml |
| | BAG: Active Agent | Dose |
|---|
| Doxorubicin Hydrochloride | 50 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum | | Sodium Chloride |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 070 | 2 Durchstechflasche(n) | 121.65 | 148.70 | A | SL | Yes |
|
